Difference between revisions of "Template:Chromalveolate antiparasitics"
Jump to navigation
Jump to search
imported>Jytdog (add) |
imported>Vaccinationist |
||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| − | | name | + | | name = Chromalveolate antiparasitics |
| − | | title | + | | title = [[Antiparasitic]]s – [[antiprotozoal agent]]s – [[Chromalveolate]] antiparasitics ([[ATC code P01|P01]]) |
| − | | listclass | + | | listclass = hlist |
| − | | state | + | | state = {{{state<includeonly>|autocollapse</includeonly>}}} |
| − | | group1 | + | | group1 = [[Alveolate|Alveo-<br>late]] |
| − | | list1 | + | | list1 = |
{{Navbox|subgroup | {{Navbox|subgroup | ||
| − | | group1 | + | | group1 = [[Apicomplexa|Apicom-<br>plexa]] |
| − | | list1 | + | | list1 = |
{{Navbox|subgroup | {{Navbox|subgroup | ||
| − | | group1 | + | | group1 = [[Conoidasida]]/<br>([[Coccidiostat]]s) |
| − | | list1 | + | | list1 = |
{{Navbox|subgroup | {{Navbox|subgroup | ||
| group1 = [[Cryptosporidiosis#Treatment|Cryptosporidiosis]] | | group1 = [[Cryptosporidiosis#Treatment|Cryptosporidiosis]] | ||
| list1 = | | list1 = | ||
| − | * ''[[thiazolide]]'' ([[nitazoxanide]]) | + | * ''[[thiazolide]]s'' ([[nitazoxanide]]) |
| group2 = [[Isosporiasis#Treatment|Isosporiasis]] | | group2 = [[Isosporiasis#Treatment|Isosporiasis]] | ||
| − | | list2 | + | | list2 = |
* [[trimethoprim/sulfamethoxazole]]<sup>#</sup> | * [[trimethoprim/sulfamethoxazole]]<sup>#</sup> | ||
| group3 = [[Toxoplasmosis#Treatment|Toxoplasmosis]] | | group3 = [[Toxoplasmosis#Treatment|Toxoplasmosis]] | ||
| − | | list3 | + | | list3 = |
* [[pyrimethamine]] | * [[pyrimethamine]] | ||
* [[sulfadiazine]] | * [[sulfadiazine]] | ||
}} | }} | ||
| − | | group2 | + | | group2 = [[Aconoidasida]] |
| − | | list2 | + | | list2 = |
{{Navbox|subgroup | {{Navbox|subgroup | ||
| − | | group1 | + | | group1 = [[Antimalarial drug|Malaria]] |
| − | | list1 | + | | list1 = |
{{Navbox|subgroup | {{Navbox|subgroup | ||
| − | | group1 | + | | group1 = Individual <br>agents |
| − | | list1 | + | | list1 = |
{{Navbox|subgroup | {{Navbox|subgroup | ||
| − | | group1 | + | | group1 = [[Hemozoin#Inhibitors|Hemozoin<br>inhibitors]] |
| − | | list1 | + | | list1 = |
{{Navbox|subgroup | {{Navbox|subgroup | ||
| − | | group1 = [[ | + | | group1 = [[Aminoquinoline]]s |
| list1 = | | list1 = | ||
* (4-): [[amodiaquine]]<sup>#</sup> | * (4-): [[amodiaquine]]<sup>#</sup> | ||
* [[chloroquine]]<sup>#</sup> | * [[chloroquine]]<sup>#</sup> | ||
| − | *[[ | + | * [[hydroxychloroquine]]<sup>#</sup> |
* (8-): [[primaquine]]<sup>#</sup> | * (8-): [[primaquine]]<sup>#</sup> | ||
| − | * [[pamaquine]] | + | * [[pamaquine]]<sup>‡</sup> |
| + | * [[tafenoquine]]<sup>†</sup> | ||
| − | | group2 = | + | | group2 = 4-Methanolquinolines |
| list2 = | | list2 = | ||
* [[mefloquine]]<sup>#</sup> | * [[mefloquine]]<sup>#</sup> | ||
| Line 65: | Line 66: | ||
| list3 = | | list3 = | ||
* [[lumefantrine]] | * [[lumefantrine]] | ||
| − | ** [[artemether/lumefantrine| | + | ** [[artemether/lumefantrine|+ artemether]]<sup>#</sup> |
* [[halofantrine]] | * [[halofantrine]] | ||
}} | }} | ||
| − | | group2 | + | | group2 = [[Antifolate]]s |
| − | | list2 | + | | list2 = |
{{Navbox|subgroup | {{Navbox|subgroup | ||
| − | | group1 = [[Dihydrofolate reductase inhibitor|DHFR inhibitors]] | + | | group1 = [[Dihydrofolate reductase inhibitor|DHFR inhibitors]] |
| list1 = | | list1 = | ||
| − | * [[pyrimethamine]] | + | * [[pyrimethamine]] |
| − | * [[ | + | * ''[[biguanide]]s'' |
| − | * [[chlorproguanil]] | + | ** [[chlorproguanil]] |
| − | ** | + | ** [[proguanil]]<sup>#</sup> |
| group2 = [[Sulfonamide (medicine)|Sulfonamides]] | | group2 = [[Sulfonamide (medicine)|Sulfonamides]] | ||
| − | | list2 | + | | list2 = |
* [[sulfadoxine]] | * [[sulfadoxine]] | ||
| − | * [[ | + | * [[sulfalene]] |
| − | | group3 = | + | | group3 = Co-formulation |
| − | | list3 | + | | list3 = |
* [[sulfadoxine/pyrimethamine]] (SP)<sup>#</sup> | * [[sulfadoxine/pyrimethamine]] (SP)<sup>#</sup> | ||
}} | }} | ||
| group3 = [[Sesquiterpene lactones|Sesquiterpene<br>lactones]] | | group3 = [[Sesquiterpene lactones|Sesquiterpene<br>lactones]] | ||
| − | | list3 | + | | list3 = |
* [[artemether]]<sup>#</sup> | * [[artemether]]<sup>#</sup> | ||
| + | * [[artemisinin]] | ||
| + | * [[artemotil]] | ||
* [[artesunate]]<sup>#</sup> | * [[artesunate]]<sup>#</sup> | ||
* [[dihydroartemisinin]] | * [[dihydroartemisinin]] | ||
| − | |||
| − | |||
| group4 = Other | | group4 = Other | ||
| − | | list4 | + | | list4 = |
| − | * [[atovaquone]] ( | + | * [[atovaquone]] ([[Atovaquone/proguanil|+ proguanil]]) |
* [[tetracycline]] | * [[tetracycline]] | ||
* [[doxycycline]]<sup>#</sup> | * [[doxycycline]]<sup>#</sup> | ||
| Line 111: | Line 112: | ||
}} | }} | ||
| − | | group2 | + | | group2 = Combi-<br>nations |
| − | | list2 | + | | list2 = |
{{Navbox|subgroup | {{Navbox|subgroup | ||
| − | | group1 = Fixed-dose ( | + | | group1 = Fixed-dose (co-formulated) [[Artemisinin|ACTs]] |
| − | | list1 | + | | list1 = |
* [[artemether/lumefantrine]]<sup>#</sup> | * [[artemether/lumefantrine]]<sup>#</sup> | ||
| + | * [[arterolane]]/piperaquine | ||
* [[artesunate/amodiaquine]] (ASAQ) | * [[artesunate/amodiaquine]] (ASAQ) | ||
* [[artesunate/mefloquine]] (ASMQ) | * [[artesunate/mefloquine]] (ASMQ) | ||
| + | * [[artesunate/pyronaridine]] | ||
* [[dihydroartemisinin/piperaquine]] | * [[dihydroartemisinin/piperaquine]] | ||
| − | |||
| − | |||
| group3 = Other combinations<br>(not co-formulated) | | group3 = Other combinations<br>(not co-formulated) | ||
| − | | list3 | + | | list3 = |
| + | * artesunate/mefloquine | ||
* artesunate/SP | * artesunate/SP | ||
| − | * | + | * quinine/clindamycin |
| + | * quinine/doxycycline | ||
* quinine/tetracycline | * quinine/tetracycline | ||
| − | |||
| − | |||
}} | }} | ||
| Line 137: | Line 138: | ||
| group2 = [[Babesiosis#Treatment|Babesiosis]] | | group2 = [[Babesiosis#Treatment|Babesiosis]] | ||
| − | | list2 | + | | list2 = |
* [[clindamycin]] | * [[clindamycin]] | ||
| Line 145: | Line 146: | ||
| group2 = [[Ciliophora|Cilio-<br>phora]] | | group2 = [[Ciliophora|Cilio-<br>phora]] | ||
| − | | list2 | + | | list2 = |
| − | * [[Balantidiasis#Treatment|Balantidiasis]]: [[ | + | * [[Balantidiasis#Treatment|Balantidiasis]]: [[tetracycline]] |
}} | }} | ||
| group2 = [[Heterokont|Hetero-<br>kont]] | | group2 = [[Heterokont|Hetero-<br>kont]] | ||
| − | | list2 | + | | list2 = |
| − | * [[Blastocystosis#Treatment|Blastocystosis]]: [[ | + | * [[Blastocystosis#Treatment|Blastocystosis]]: [[metronidazole]] |
| belowstyle = background: transparent; padding: 0px; | | belowstyle = background: transparent; padding: 0px; | ||
| Line 158: | Line 159: | ||
}}<noinclude> | }}<noinclude> | ||
| + | |||
{{collapsible option}} | {{collapsible option}} | ||
| + | |||
[[Category:Antiprotozoal agents]] | [[Category:Antiprotozoal agents]] | ||
[[Category:Drug_templates by ATC]] | [[Category:Drug_templates by ATC]] | ||
| + | |||
</noinclude> | </noinclude> | ||
Revision as of 13:37, 14 July 2016
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Chromalveolate antiparasitics|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Chromalveolate antiparasitics|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Chromalveolate antiparasitics|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.